Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 1.000 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.674 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.662 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.583 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.573 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.542 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.541 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.524 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.523 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.521 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.513 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.506 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.500 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.498 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.495 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.494 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.494 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.492 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.480 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.478 | |
| 3vt7 | VDX | Vitamin D3 receptor | / | 0.477 | |
| 3vt9 | YI4 | Vitamin D3 receptor | / | 0.476 | |
| 3ogq | AB1 | Pol polyprotein | / | 0.474 | |
| 1jip | KTN | 6-deoxyerythronolide B hydroxylase | / | 0.473 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.473 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.471 | |
| 4nxu | ADP | Mitochondrial dynamics protein MID51 | / | 0.469 | |
| 2ca0 | PXI | Cytochrome P450 monooxygenase PikC | / | 0.467 | |
| 2po7 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.466 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 4aw3 | MYV | Mycinamicin IV hydroxylase/epoxidase | / | 0.465 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.461 | |
| 4ylf | FAD | Dihydroorotate dehydrogenase B (NAD(+)), electron transfer subunit homolog | / | 0.460 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 1jio | DEB | 6-deoxyerythronolide B hydroxylase | / | 0.457 | |
| 1yb5 | NAP | Quinone oxidoreductase | 1.6.5.5 | 0.457 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.456 | |
| 2pob | GW4 | Peroxisome proliferator-activated receptor gamma | / | 0.456 | |
| 4dit | 0KD | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.456 | |
| 2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.454 | |
| 3tqh | NDP | Quinone oxidoreductase | / | 0.454 | |
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 0.453 | |
| 2hw2 | RFP | Rifampin ADP-ribosyl transferase | / | 0.453 | |
| 4hjo | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.452 | |
| 2vn0 | TDZ | Cytochrome P450 2C8 | / | 0.452 | |
| 3hv5 | R24 | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 3i59 | N6R | CRP-like cAMP-activated global transcriptional regulator | / | 0.452 | |
| 4e4q | RRH | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 4xld | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.452 | |
| 1ie8 | KH1 | Vitamin D3 receptor | / | 0.451 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 1rv1 | IMZ | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.450 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.450 | |
| 2q5p | 241 | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
| 3vt8 | YI3 | Vitamin D3 receptor | / | 0.450 | |
| 4nxw | ADP | Mitochondrial dynamics protein MID51 | / | 0.450 | |
| 4o2b | LOC | Tubulin beta-2B chain | / | 0.450 | |
| 1dxq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.449 | |
| 1k6t | XN1 | Gag-Pol polyprotein | 3.4.23.16 | 0.449 | |
| 3zuy | TCH | Transporter | / | 0.449 | |
| 4b7d | QLE | Cytochrome P450 monooxygenase PikC | / | 0.449 | |
| 4b7s | QLE | Cytochrome P450 monooxygenase PikC | / | 0.449 | |
| 4k2x | FAD | Polyketide oxygenase/hydroxylase | / | 0.449 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.449 | |
| 4xgx | ADP | FAD:protein FMN transferase | / | 0.449 | |
| 2w2l | NAD | D-mandelate dehydrogenase | / | 0.448 | |
| 3k4n | FAD | Pyranose 2-oxidase | / | 0.448 | |
| 3rj5 | NAD | Alcohol dehydrogenase | 1.1.1.1 | 0.448 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.448 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.447 | |
| 1s0z | EB1 | Vitamin D3 receptor | / | 0.447 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.447 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.446 | |
| 2w0j | ZAT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.446 | |
| 2znq | 401 | Peroxisome proliferator-activated receptor delta | / | 0.446 | |
| 3ml8 | ML8 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.446 | |
| 4a6b | QG8 | Gag-Pol polyprotein | 3.4.23.16 | 0.446 | |
| 4jay | FAD | UDP-N-acetylenolpyruvoylglucosamine reductase | / | 0.446 | |
| 1kkq | 471 | Peroxisome proliferator-activated receptor alpha | / | 0.445 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 2p4y | C03 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 3gw9 | VNI | Lanosterol 14-alpha-demethylase | / | 0.445 | |
| 4fhi | 0S4 | Vitamin D3 receptor A | / | 0.445 | |
| 4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.445 | |
| 5fkm | TDC | Tetracycline repressor protein class D | / | 0.445 | |
| 1tw4 | CHD | Fatty acid-binding protein, liver | / | 0.444 | |
| 1zar | ADP | RIO-type serine/threonine-protein kinase Rio2 | 2.7.11.1 | 0.444 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 2c6h | PXI | Cytochrome P450 monooxygenase PikC | / | 0.444 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.444 | |
| 2qo4 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.444 | |
| 3w0y | DS4 | Vitamin D3 receptor | / | 0.444 | |
| 5eai | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.444 | |
| 1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.443 | |
| 2npa | MMB | Peroxisome proliferator-activated receptor alpha | / | 0.443 | |
| 3v9v | 21L | Peroxisome proliferator-activated receptor gamma | / | 0.443 | |
| 4nky | 3QZ | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.443 | |
| 4q73 | FAD | Bifunctional protein PutA | / | 0.443 | |
| 1fm9 | 570 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.442 | |
| 1zgy | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 2w9s | TOP | Dihydrofolate reductase type 1 from Tn4003 | 1.5.1.3 | 0.442 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.442 | |
| 3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.442 | |
| 3w5r | LOA | Vitamin D3 receptor | / | 0.442 | |
| 4aa0 | AA0 | Mitogen-activated protein kinase 14 | / | 0.442 | |
| 4i3w | NAD | Aldehyde dehydrogenase (NAD+) | / | 0.442 | |
| 4otw | DB8 | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.442 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.442 | |
| 2f4b | EHA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2hwr | DRD | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.441 | |
| 2jn3 | JN3 | Fatty acid-binding protein, liver | / | 0.441 | |
| 3frq | ERY | Erythromycin resistance repressor protein | / | 0.441 | |
| 4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 5itz | LOC | Tubulin beta-2B chain | / | 0.441 | |
| 1sn5 | T3 | Transthyretin | / | 0.440 | |
| 1zhw | HC2 | Oxysterol-binding protein homolog 4 | / | 0.440 | |
| 2har | OCC | Vitamin D3 receptor | / | 0.440 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.440 |